Charlottesville, Va.-based UVA Health is swapping traditional plastic pill bottles for recyclable containers called Tully Tubes to reduce waste and cut carbon admissions, according to an April 22 news release. The bottles, developed by Parcel Health, are made from 100%…
Pharmacy
Millions of Medicaid beneficiaries have limited access to Type 2 diabetes medications that reduce the risk of cardiovascular disease, according to a study published April 22 in Annals of Internal Medicine. An analysis of 50 state Medicaid plans and 273…
Lurie Children’s Hospital, based in Chicago, will open its first outpatient specialty pharmacy in partnership with Clearway Health. The 2,050-square-foot facility, set to open in late 2026, will be on the third floor of the new Lurie Children’s Outpatient and…
A coalition of 39 state attorneys general called on Congress to pass legislation prohibiting pharmacy benefit managers and parent companies from owning or operating pharmacies. In an April 14 letter, the attorneys general said such ownership practices distort competition, drive…
The FDA has approved Dupixent as the first new targeted therapy in over ten years for chronic spontaneous urticaria in patients aged 12 and older who remain symptomatic despite antihistamine treatment. The approval is based on data from three phase…
Advertisement
Commonly prescribed medications such as statins, non-steroidal anti-inflammatory drugs and certain blood pressure drugs may significantly delay the onset of Parkinson’s disease. The study, published in Journal of Neurology, reviewed medical records from over 1,200 Parkinson’s disease patients examined by…
In recent weeks, biotech companies have faced setbacks in moving forward with clinical trials due to operational delays at the FDA, according to an exclusive report from The Wall Street Journal published April 17. Five things to know:
Arkansas has become the first state to ban pharmacy benefit managers from owning pharmacies after Gov. Sarah Huckabee Sanders signed House Bill 1150 into law April 16. The legislation, sponsored by state Rep. Jeremiah Moore and state Sen. Kim Hammer,…
Mark Cuban’s latest move to disrupt the pharmaceutical supply chain is expanding — this time, tackling the injectable drug market through a new partnership with distributor Morris & Dickson. His company, Mark Cuban Cost Plus Drug Co., is partnering with…
Glenmark Pharmaceuticals has voluntarily recalled 24 generic prescription drugs distributed in the U.S. following concerns about potential cross-contamination at a manufacturing facility in Pithampur, India. The recall follows an FDA inspection in February that found cleaning and testing lapses, according…